Department of Economics, Vanderbilt University, Nashville, Tennessee, USA.
Health Econ. 2022 Aug;31(8):1649-1675. doi: 10.1002/hec.4530. Epub 2022 May 23.
This paper documents how substance abuse treatment (SAT) providers and services respond to increases in population-level opioid addiction. I do this by exploiting the implementation of Medicare Part D as an exogenous increase in the availability of prescription opioids. Starting in 2006, states with higher shares of the population eligible for Medicare Part D experienced increases in residential and hospital inpatient SAT facilities, beds dedicated to SAT, and SAT facilities offering medication-assisted treatment, relative to states with lower shares. These results suggest that the supply of SAT in the United States is capable of responding significantly to changes in demand.
本文记录了物质滥用治疗（SAT）提供者和服务如何应对人群中阿片类药物成瘾的增加。我通过利用医疗保险部分 D 的实施作为处方类阿片类药物供应增加的外生变量来实现这一目标。从 2006 年开始，符合医疗保险部分 D 资格的人群比例较高的州，与比例较低的州相比，住宅和医院住院 SAT 设施、专门用于 SAT 的床位以及提供药物辅助治疗的 SAT 设施有所增加。这些结果表明，美国 SAT 的供应能够对需求变化做出显著反应。
